Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis
Kim A, Woo W, Yon D, Lee S, Yang J, Kim J, Park S, Koyanagi A, Kim M, Lee S, Shin J, Smith L. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis. International Journal Of Infectious Diseases 2022, 119: 130-139. PMID: 35339716, PMCID: PMC8942584, DOI: 10.1016/j.ijid.2022.03.034.Peer-Reviewed Original ResearchConceptsVaccine-induced immune thrombotic thrombocytopeniaCerebral venous thrombosisChAdOx1 nCoV-19 vaccineSplanchnic vein thrombosisThrombotic thrombocytopeniaVein thrombosisVenous thrombosisClinical outcomesMeta-analysisRate of cerebral venous thrombosisAge of patientsPooled incidence rateAdenoviral vector vaccinesSARS-CoV-2 vaccinesSite of thrombosisChAdOx1 nCoV-19Between-study heterogeneityAnticoagulant treatmentNo significant differenceFemale predominanceClinical manifestationsExtracranial thrombosisIntracranial haemorrhageFatal outcomeOverall mortality
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply